References
Zhao SP, Liu L, Cheng YC, Shishehbor MH, Liu MH, Peng DQ, Li YL. Xuezhikang, an extract of cholestin, protects endothelial function through anti-inflammatory and lipid-lowering mechanisms in patients with coronary heard disease. Circulation 2004;110:915–20.
McGowan MP, Treating to New Target Study Group. There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients. Circulation 2004;110(16):2333–5, Oct 19.
Robinson JG, Smith B, Maheshwari N, Schrott H. Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis. J Am Coll Cardiol 2005;46(10):1855–62.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bruckert, E. A New Approach to Decrease Serum Cholesterol Levels. Cardiovasc Drugs Ther 20, 157–158 (2006). https://doi.org/10.1007/s10557-006-8800-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10557-006-8800-y